Hello everyone.
Can someone explain to me what does the lambda, K, and E means?
The result is generated using ssearch35 software.
or maybe can share the user guide or manual?
Thank in advance.
Query: 641, 114 nt
1>>>641 - 114 nt - 114 nt641.txt
Library: ss35.txt 37666 residues in 11 sequences
37666 residues in 11 sequences
Statistics: (shuffled [500]) MLE statistics: Lambda= 0.1448; K=0.1411
Algorithm: Smith-Waterman (PGopt) (6.0 Mar 2007)
Parameters: +5/-4 matrix (5:-4), open/ext: -12/-4
The best scores are: s-w bits E(11)
11 (3426) [f] 570 121.9 8.6e-031
7 (3426) [f] 570 121.9 8.6e-031
s10 (3425) [f] 570 121.9 8.6e-031
9 (3425) [f] 570 121.9 8.6e-031
s4 (3425) [f] 570 121.9 8.6e-031
2 (3425) [f] 570 121.9 8.6e-031
6 (3422) [f] 570 121.9 8.6e-031
5 (3422) [f] 570 121.9 8.6e-031
3 (3422) [f] 570 121.9 8.6e-031
1 (3424) [f] 570 121.9 8.6e-031
8 (3424) [f] 570 121.9 8.6e-031
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...